TSE:I Intellipharmaceutics International (I) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$3.23▼C$3.2352-Week Range N/AVolume7,625 shsAverage Volume16,872 shsMarket CapitalizationC$97.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Intellipharmaceutics International alerts: Email Address Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Intellipharmaceutics InternationalIntellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.Read More Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << I Stock News HeadlinesApril 22, 2024 | finance.yahoo.comSuper Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest StudyFebruary 19, 2024 | theglobeandmail.comIntelliPharmaCeutics Intl: Top 10 Undervalued Biotechnology Industry Stocks (IPCI)September 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… January 3, 2024 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Wednesday (IPCI)December 7, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Tuesday (IPCI)October 16, 2023 | msn.comIntellipharmaceutics International GAAP EPS of -$0.06October 13, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Friday (IPCI)July 6, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Wednesday (IPCI)September 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… June 29, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Tuesday (IPCI)June 13, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Monday (IPCI)April 18, 2023 | finance.yahoo.comIntellipharmaceutics International Inc. (I4AA.F)April 7, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Wednesday (IPCI)April 5, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Monday (IPCI)April 4, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Friday (IPCI)February 7, 2023 | yahoo.comIntellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade OrderJanuary 13, 2023 | finance.yahoo.comIntellipharmaceutics International Inc. (IPCIF)August 30, 2022 | thestreet.comChanges at the Top for Endo Could Benefit Its Smaller PartnersSee More Headlines Receive I Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorBusiness Services Industry Wireless Telecommunications Sub-IndustryCommunication Current SymbolTSE:I CUSIPN/A CIKN/A Webwww.intelsat.com Phone+1-416-7983001FaxN/AEmployees1,069Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,156,000Free FloatN/AMarket CapC$97.40 million OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesIsa Odidi Ph.D.Chairman of the Board, Chief Executive OfficerAmina Odidi Ph.D.President, Chief Operating Officer, DirectorAndrew PatientChief Financial OfficerJohn N. AllportVice President - Legal Affairs and Licensing, Secretary, DirectorPatrick N. Yat Ph.D.Vice President - Pharmaceutical Analysis and ChemistryKenneth KeirsteadIndependent DirectorBahadur MadhaniIndependent DirectorEldon R. Smith M.D. (Age 75)Independent Director More ExecutivesKey CompetitorsNeuLionTSE:NLNAmex ExplorationCVE:AMXBMO MSCI China ESG Leaders Index ETFTSE:ZCHPrimero MiningTSE:PCorus EntertainmentTSE:CJR.BView All Competitors I Stock Analysis - Frequently Asked Questions How do I buy shares of Intellipharmaceutics International? Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Intellipharmaceutics International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intellipharmaceutics International investors own include QuickLogic (QUIK), VBI Vaccines (VBIV), NeuLion (NLN), Micron Technology (MU), Mallinckrodt (MNK), Intellipharmaceutics International (IPCIF) and Fitbit (FIT). This page (TSE:I) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
